SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001273087-24-000038
Filing Date
2024-02-06
Accepted
2024-02-06 16:12:43
Documents
1
Group Members
ISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 ORIC_SC13GA.htm SC 13G/A 79723
  Complete submission text file 0001273087-24-000038.txt   81630
Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
MILLENNIUM MANAGEMENT LLC (Filed by) CIK: 0001273087 (see all company filings)

IRS No.: 133804139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Subject) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91490 | Film No.: 24600395
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)